Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Peripheral Nervous System Diseases

1-methyl-3-isobutylxanthine has been researched along with Peripheral Nervous System Diseases in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chłoń-Rzepa, G1
Ślusarczyk, M1
Jankowska, A1
Gawalska, A1
Bucki, A1
Kołaczkowski, M1
Świerczek, A1
Pociecha, K1
Wyska, E1
Zygmunt, M1
Kazek, G1
Sałat, K1
Pawłowski, M1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Peripheral Nervous System Diseases

ArticleYear
Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Amides; Analgesics; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phospho

2018